Exact Sciences
EXAS
#1764
Rank
$9.52 B
Marketcap
$51.48
Share price
-3.29%
Change (1 day)
-13.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - P/B ratio

P/B ratio as of November 2024 : 2.98

According to Exact Sciences's latest financial reports the company has a price-to-book ratio of 3.64765.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Exact Sciences - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.2547.15%
2022-12-312.89-27.55%
2021-12-313.99-55.24%
2020-12-318.9149.41%
2019-12-315.97-47.73%
2018-12-3111.4-5.56%
2017-12-3112.1179.83%
2016-12-314.3258.23%
2015-12-312.73-67.56%
2014-12-318.4236.36%
2013-12-316.17-10.1%
2012-12-316.8633.36%
2011-12-315.1531.61%
2010-12-313.91-80.21%
2009-12-3119.8-409.56%
2008-12-31-6.38-145.93%
2007-12-3113.9174.32%
2006-12-315.07113.5%
2005-12-312.37-10.47%
2004-12-312.65-83.41%
2003-12-3116.0196.69%
2002-12-315.39

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.14-28.45%๐Ÿ‡บ๐Ÿ‡ธ USA
2.50-16.36%๐Ÿ‡บ๐Ÿ‡ธ USA
3.94 31.95%๐Ÿ‡บ๐Ÿ‡ธ USA
1.65-44.86%๐Ÿ‡ซ๐Ÿ‡ท France